Optimal Duration of Anticoagulation Therapy for Low-risk Pulmonary Embolism Patients With Cancer

Clinical trial NCT04724460 · COMPLETED

Trial details

NCT number: NCT04724460
Sponsor: Takeshi Morimoto
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Venous Thrombosis Neoplasms Anticoagulants

Start date: 2021-02-18
Primary completion: 2024-09-27
Enrollment: 179

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.